Scientific summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) program 10th Anniversary Conference
Wendy Woodward
(1)
,
Massimo Cristofanilli
(2)
,
Sofia Merajver
(3, 4)
,
Steven van Laere
(5)
,
Lajos Pusztai
(6)
,
François Bertucci
(7)
,
Fedor Berditchevski
(8)
,
Kornelia Polyak
(9)
,
Beth Overmoyer
(10)
,
Gayathri Devi
(11)
,
Esta Sterneck
(12)
,
Robert Schneider
(13, 14)
,
Bisrat Debeb
(15)
,
Xiaoping Wang
(15)
,
Kenneth van Golen
(16)
,
Randa El-Zein
(17, 1)
,
Omar Rahal
(15)
,
Angela Alexander
(15, 18)
,
James Reuben
(15)
,
Savitri Krishnamurthy
(19)
,
Anthony Lucci
(15)
,
Naoto Ueno
(15)
1
The University of Texas M.D. Anderson Cancer Center [Houston]
2 Northwestern University Feinberg School of Medicine
3 Department of Inteernal Medicine
4 University of Michigan Medical School [Ann Arbor]
5 CORE - Center for Oncological Research [Antwerp, Belgium]
6 Department of Neuroscience, Yale University School of Medicine
7 CRCM - Centre de Recherche en Cancérologie de Marseille
8 Institute of Cancer and Genomic Sciences, University of Birmingham
9 Department of Medical Oncology
10 Dana-Farber Cancer Institute [Boston]
11 Duke University Medical Center
12 FNLCR - Frederick National Laboratory for Cancer Research
13 NYU - New York University School of Medicine
14 NYUP2C - NYU Perlmutter Cancer Center [New York, NY, USA]
15 MD Anderson Cancer Center [Houston]
16 University of Delaware [Newark]
17 Houston Methodist Research Institute
18 The University of Texas Medical School at Houston
19 CSE - Department of Computer Science & Engineering [Riverside]
2 Northwestern University Feinberg School of Medicine
3 Department of Inteernal Medicine
4 University of Michigan Medical School [Ann Arbor]
5 CORE - Center for Oncological Research [Antwerp, Belgium]
6 Department of Neuroscience, Yale University School of Medicine
7 CRCM - Centre de Recherche en Cancérologie de Marseille
8 Institute of Cancer and Genomic Sciences, University of Birmingham
9 Department of Medical Oncology
10 Dana-Farber Cancer Institute [Boston]
11 Duke University Medical Center
12 FNLCR - Frederick National Laboratory for Cancer Research
13 NYU - New York University School of Medicine
14 NYUP2C - NYU Perlmutter Cancer Center [New York, NY, USA]
15 MD Anderson Cancer Center [Houston]
16 University of Delaware [Newark]
17 Houston Methodist Research Institute
18 The University of Texas Medical School at Houston
19 CSE - Department of Computer Science & Engineering [Riverside]
Wendy Woodward
- Function : Author
- PersonId : 824117
- ORCID : 0000-0002-7935-739X
Massimo Cristofanilli
- Function : Author
- PersonId : 824155
- ORCID : 0000-0002-4194-7175
Steven van Laere
- Function : Author
- PersonId : 779440
- ORCID : 0000-0003-2465-3252
François Bertucci
- Function : Author
- PersonId : 753650
- IdHAL : francois-bertucci
- ORCID : 0000-0002-0157-0959
Gayathri Devi
- Function : Author
- PersonId : 824104
- ORCID : 0000-0001-9158-7289
Robert Schneider
- Function : Author
- PersonId : 759754
- ORCID : 0000-0003-3279-5365
- IdRef : 224230360
Naoto Ueno
- Function : Author
- PersonId : 791524
- ORCID : 0000-0002-0166-7275
- IdRef : 185431739
Abstract
In 2006, a remarkable collaboration between University of Texas MD Anderson Cancer Center clinicians and
Texas and New Mexico State legislators led to the formation of a dedicated IBC Research Program and Clinic
at MD Anderson. This initiative provided funding and infrastructure to foster coordination of an IBC World
Consortium of national and international experts, and launch the first ever IBC international conference in
2008, which brought together experts from around the world to facilitate collaborations and accelerate
progress. Indeed great progress has been made since then. National and international experts in IBC
convened at the 10th Anniversary Conference of the MD Anderson IBC Clinic and Research Program and
presented the most extensive sequencing analysis to date comparing IBC to non-IBC, gene- and
protein-based immunoprofiling of IBC versus non-IBC patients, and converging lines of evidence on the
specific role of the microenvironment in IBC. Novel models, unique metabolic mechanisms, and prominent
survival pathways have been identified and were presented. Multiple clinical trials based on the work of the
last decade are in progress or in development. The important challenges ahead were discussed. This progress
and a coordinated summary of these works are presented herein.